Theriva Biologics, Inc. (TOVX)
AMEX·Healthcare·Biotechnology
$0.35
-1.10%
Mkt Cap $12.62M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | — | — | — | -$0.43 | $1.85 | +525.29% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.38 | -$0.45 | -18.42% | — | — |
| Q3 2025 Aug 11, 2025 | — | — | — | -$0.38 | -$1.93 | -407.89% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$4.19 | -$1.55 | +63.01% | — | — |
| Q1 2025 Mar 6, 2025 | — | $154.00K | — | -$6.36 | -$3.30 | +48.11% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$6.25 | -$6.81 | -8.96% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$4.75 | -$5.50 | -15.79% | — | — |
| Q2 2024 May 7, 2024 | — | — | — | -$0.34 | -$7.50 | -2105.88% | — | — |
| Q1 2024 Mar 25, 2024 | — | $758.00K | — | -$0.41 | -$8.00 | -1851.22% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.37 | -$4.75 | -1183.78% | — | — |
| Q3 2023 Aug 8, 2023 | — | — | — | -$0.36 | -$8.50 | -2261.11% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.32 | -$7.50 | -2243.75% | — | — |
| Q1 2023 Mar 30, 2023 | — | — | — | $0.33 | -$9.00 | -2827.27% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$0.39 | -$8.25 | -2015.38% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$0.35 | -$0.31 | +11.43% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | -$0.30 | -$0.30 | +0.00% | — | — |
| Q1 2022 Mar 16, 2022 | — | — | — | -$0.30 | -$0.40 | -33.33% | — | — |
| Q4 2021 Nov 3, 2021 | — | — | — | -$0.25 | -$0.20 | +20.00% | — | — |
| Q3 2021 Aug 5, 2021 | — | — | — | -$0.20 | -$0.20 | +0.00% | — | — |
| Q2 2021 May 5, 2021 | — | — | — | -$0.20 | -$1.30 | -550.00% | — | — |